John S Kovach - Net Worth and Insider Trading

John S Kovach Net Worth

The estimated net worth of John S Kovach is at least $374,110 dollars as of 2024-05-26. John S Kovach is the President and CEO, 10% Owner of Lixte Biotechnology Holdings Inc and owns about 154,018 shares of Lixte Biotechnology Holdings Inc (LIXT) stock worth over $374,110. Details can be seen in John S Kovach's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John S Kovach has not made any transactions after 2020-11-30 and currently still holds the listed stock(s).

Transaction Summary of John S Kovach

To

John S Kovach Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John S Kovach owns 1 companies in total, including Lixte Biotechnology Holdings Inc (LIXT) .

Click here to see the complete history of John S Kovach’s form 4 insider trades.

Insider Ownership Summary of John S Kovach

Ticker Comapny Transaction Date Type of Owner
LIXT Lixte Biotechnology Holdings Inc 2020-11-30 director & 10 percent owner & Pres. & CFO & Secty

John S Kovach Latest Holdings Summary

John S Kovach currently owns a total of 1 stock. John S Kovach owns 154,018 shares of Lixte Biotechnology Holdings Inc (LIXT) as of November 30, 2020, with a value of $374,110.

Latest Holdings of John S Kovach

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LIXT Lixte Biotechnology Holdings Inc 2020-11-30 154,018 2.43 374,110

Holding Weightings of John S Kovach


John S Kovach Form 4 Trading Tracker

According to the SEC Form 4 filings, John S Kovach has made a total of 1 transactions in Lixte Biotechnology Holdings Inc (LIXT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lixte Biotechnology Holdings Inc is the acquisition of 2,110 shares on November 30, 2020, which cost John S Kovach around $100,225.

Insider Trading History of John S Kovach

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John S Kovach Trading Performance

GuruFocus tracks the stock performance after each of John S Kovach's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John S Kovach is 7.92%. GuruFocus also compares John S Kovach's trading performance to market benchmark return within the same time period. The performance of stocks bought by John S Kovach within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John S Kovach's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John S Kovach

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.47
Relative Return to S&P 500(%) -21.52

John S Kovach Ownership Network

Ownership Network List of John S Kovach

No Data

Ownership Network Relation of John S Kovach


John S Kovach Owned Company Details

What does Lixte Biotechnology Holdings Inc do?

Who are the key executives at Lixte Biotechnology Holdings Inc?

John S Kovach is the director & 10 percent owner & Pres. & CFO & Secty of Lixte Biotechnology Holdings Inc. Other key executives at Lixte Biotechnology Holdings Inc include 10 percent owner Eric Forman , 10 percent owner Glenn Krinsky , and 10 percent owner Robert Greenberg .

Lixte Biotechnology Holdings Inc (LIXT) Insider Trades Summary

Over the past 18 months, John S Kovach made no insider transaction in Lixte Biotechnology Holdings Inc (LIXT). Other recent insider transactions involving Lixte Biotechnology Holdings Inc (LIXT) include a net purchase of 45,000 shares made by Rene Bernards , a net purchase of 16,112 shares made by Eric Forman , and a net purchase of 10,000 shares made by Van Der Baan Bastiaan Jeroen .

In summary, during the past 3 months, insiders sold 0 shares of Lixte Biotechnology Holdings Inc (LIXT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lixte Biotechnology Holdings Inc (LIXT) were sold and 34,111 shares were bought by its insiders, resulting in a net purchase of 34,111 shares.

Lixte Biotechnology Holdings Inc (LIXT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lixte Biotechnology Holdings Inc Insider Transactions

No Available Data

John S Kovach Mailing Address

Above is the net worth, insider trading, and ownership report for John S Kovach. You might contact John S Kovach via mailing address: 1801 Century Park East #1600, Los Angeles Ca 90067.

Discussions on John S Kovach

No discussions yet.